For all media queries please contact our Communications Advisor.
Medicines New Zealand is pleased that the New Zealand Government has today announced an additional investment of $60 million towards new medicines.
Medicines New Zealand today released their latest Annual Report, The New Zealand Medicines Landscape 2016. It reveals patients in New Zealand are at the end of the queue for cost-effective, innovative medicines compared with other countries.
Dr Paul Young has been awarded the Medicines New Zealand’s 2016 Value of Medicines Award for leading a world-class study into the effects paracetamol has on patients in intensive care units (ICU).